Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
City of Hope Medical Center
Dana-Farber Cancer Institute
Incyte Corporation
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Institut Bergonié
NGM Biopharmaceuticals, Inc
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Stanford University
Rain Oncology Inc
Pfizer
Pfizer
ADC Therapeutics S.A.
pharmaand GmbH
Exelixis
Sumitomo Pharma America, Inc.
Pfizer
pharmaand GmbH
Pfizer
Children's Oncology Group
Hoffmann-La Roche
pharmaand GmbH
M.D. Anderson Cancer Center
Hoffmann-La Roche
City of Hope Medical Center
OncoNano Medicine, Inc.
Revolution Medicines, Inc.
Fred Hutchinson Cancer Center
Herlev Hospital
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Duke University
Hoosier Cancer Research Network
Masonic Cancer Center, University of Minnesota
Five Prime Therapeutics, Inc.
Incyte Corporation
Seagen Inc.
EMD Serono
Seagen Inc.
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Incyte Corporation
Seagen Inc.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company